🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOrforglipron Phase 3 ATTAIN-1 topline — anyone have experience? Page 4

Orforglipron Phase 3 ATTAIN-1 topline — anyone have experience?

steve_okc Sat, Apr 26, 2025 at 11:16 AM 30 replies 1,800 viewsPage 4 of 6
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
May 1, 2025 at 3:57 AM#16

Clinical perspective, offered as context rather than as advice. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Ask again with the specifics and you will get a better answer than this one.

Last edited: May 1, 2025 at 4:57 AM
5 3hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 2 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 1, 2025 at 3:19 PM#17

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

6 4dave_SLC, FDA_TrackerJim, ricardo_MIA and 3 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
May 2, 2025 at 2:41 AM#18

One thing that is still open after HPLC_Greg’s answer:

How would you tell the difference between that and the alternative explanation?

Last edited: May 2, 2025 at 3:41 AM
7 5BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 4 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
May 2, 2025 at 2:03 PM#19
PeptideChemSF said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

This is where I part company with the consensus forming above. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

Last edited: May 2, 2025 at 8:03 PM
8 6labquiet_amy, emily_PDX, Dr.SleepRoch and 5 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 3, 2025 at 1:25 AM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

30 3PurityPaulOR, MaxMetOK, MounjBrad and 27 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register